Skip to main content
UCL Logo Navigate back to homepage

Main navigation

  • Home
  • Study

    Study

    • Study at UCL
    • Prospective students
    • Current students
    • Accommodation
    • Careers
    • Doctoral School
    • Immigration and visas
    • Student finances
    • Support and wellbeing
  • Research

    Research

    • Research at UCL
    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage

    Engage

    • Engage with UCL
    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Policy and political engagement
    • Schools and priority groups
    • Give to UCL
  • About

    About

    • About UCL
    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
    • UCL's Bicentenary
  • UCL Logo Active parent page: Faculty of Medical Sciences
    • Study
    • Research
    • Divisions and Institutes
    • Events
    • About
    • Active parent page: News
    • Contacts

Linking HIV positive people to care in rural KwaZulu-Natal remains challenge

The research published in the Lancet HIV is the first that uses longitudinal, individual-level data across all stages of the cascade, from infection through to therapeutic response.

2 February 2017

Credit: Ben Gilbert, Wellcome; Samora Chapman; Greg Lomas

Breadcrumb trail

  • Faculty of Medical Sciences

Faculty menu

  • Study
  • Research
  • Divisions and Institutes
  • Events
  • About
  • Current page: News
  • Contacts

Breadcrumb trail

  • Faculty of Medical Sciences
  • Linking HIV positive people to care in rural KwaZulu-Natal remains challenge

Research published in the Lancet HIV shows that linking HIV infected people to clinical care and treatment is a critical gap in the South African Health Department’s HIV treatment programme in rural KwaZulu-Natal.

The research utilises one of the most comprehensive clinical and population surveillance databases in the world in order to quantify each stage in the HIV cascade of care. The HIV cascade of care describes discrete, consecutive stages through which people with HIV pass within a healthcare system. The HIV care cascade is now recognised as an essential factor in determining how effectively infected individuals are diagnosed, linked into clinical care for antiretroviral treatment, and how well that treatment is working to improve their health. This paper is the first that uses longitudinal (across time), individual-level data across all stages of the cascade, from infection through to therapeutic response.

From 2006, after the initial rollout of antiretroviral therapy, until 2014 Africa Health Research Institute (AHRI) scientists followed up with 5205 people living with HIV in the mostly rural area of Hlabisa in KZN. During this time, researchers recorded 598 deaths, 4539 people learned of their HIV positive status, 2818 were linked to care, 2151 became eligible for antiretroviral treatment (ART), 1839 began ART, and 1456 had a successful response to therapy.

However, in this study statistics show that two years after testing positive in the population study, of the 66% who knew their status only 25% were linked to care. On average, linking to care took over four years. The researchers’ findings show that while there have been significant improvements to the HIV diagnosis process, a bottleneck in the system is the immediate linking of HIV positive people to clinical care.

Links

  • Source: Africa Health Research Institute (AHRI) news
  • Read the paper: Lancet HIV

Image

(Credit: Ben Gilbert, Wellcome; Samora Chapman; Greg Lomas)

Highlights in Medical Sciences

Groundbreaking bowel cancer trial follow-up shows zero relapses
close up view of a mans arm while having an IV immunoglobulin infusion at hospital

Research

Groundbreaking bowel cancer trial follow-up shows zero relapses

Patients with a specific bowel cancer who were given short-course immunotherapy before surgery, instead of post-op chemotherapy, remained cancer-free after nearly three years of follow-up.

Drug to treat aggressive leukaemia approved for use in adults
Fluorescence microscopy image of immune cells, showing blue-stained nuclei surrounded by green cell membranes with red marker signals indicating specific proteins or activity within the cells.

Research

Drug to treat aggressive leukaemia approved for use in adults

Adult patients with aggressive leukaemia will soon be able to receive a breakthrough immunotherapy, developed by UCL researchers, on the NHS after approval by NICE.

Millions could benefit from faster prostate cancer scan
healthy prostate scan

Research

Millions could benefit from faster prostate cancer scan

Results of the PRIME trial involving UCL Medical Sciences researchers have found that a quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan.

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources
UCL Logo

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

UCL social media menu

  • Link to Instagram
  • Link to LinkedIn
  • Link to Youtube
  • Link to TikTok
  • Link to Facebook
  • Link to Bluesky
  • Link to Threads
  • Link to Soundcloud
Here, it can happen.
Back to top

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in

© 2026 UCL